Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Huse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2003 - 2007- University of Pennsylvania Health SystemFellowship, Neuropathology, 2004 - 2006
Perelman School of Medicine at the University of PennsylvaniaClass of 2003
Certifications & Licensure
TX State Medical License 2016 - 2026
NY State Medical License 2008 - 2017
PA State Medical License 2003 - 2008
American Board of Pathology Pathology - Anatomic- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 3 citationsG-quadruplex stabilizer CX-5461 effectively combines with radiotherapy to target α-thalassemia/mental retardation X-linked-deficient malignant glioma.Sharvari Dharmaiah, Prit Benny Malgulwar, William E Johnson, Brandon A Chen, Vladislav Sharin
Neuro-Oncology. 2025-05-15 - Comparative pathology boards facilitate the translation of knowledge between canine and human cancer patients.Jessica A Beck, Christina Mazcko, Sara Belluco, Mireille Bitar, Daniel Brat
Brain Pathology. 2025-05-05 - Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad Scope and Implementation - A Progress Report.Martin J van den Bent, Michael A Vogelbaum, Tim Cloughesy, Norbert Galldiks, Nathalie L Albert
Neuro-Oncology. 2025-05-03
Press Mentions
MD Anderson Research Highlights for March 12, 2025March 12th, 2025- MD Anderson Unveils Key Research Breakthroughs: Highlights from March 12, 2025March 12th, 2025
- MD Anderson Research Highlights for January 9, 2025January 9th, 2025
- Join now to see all
Grant Support
- Characterizing germline and somatic alterations by glioma subtypes and clinical outcomeSTANFORD UNIVERSITY2019–2025
- Characterizing heterochromatin dysfunction as a driving alteration in cancerUNIVERSITY OF TX MD ANDERSON CAN CTR2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
